Max Robotics — Global Service Robot Directory + US Certification

About

Lin Hao is a pioneering thoracic surgeon whose research has significantly advanced the field of minimally invasive thoracic oncology, with particular expertise in robotic-assisted thoracic surgery (RATS) and its comparative efficacy against conventional surgical approaches. Among the first to introduce robot-assisted thoracoscopic lobectomy in mainland China in 2009, Hao has played a foundational role in establishing and refining robotic surgery protocols across the country, as evidenced by his 2010 initial experience report and subsequent landmark studies. His most-cited work (74 citations) compares robotic and video-assisted thoracoscopic surgery (VATS) for locally advanced non-small cell lung cancer (NSCLC), while other highly influential studies examine perioperative outcomes across large patient cohorts and multiple surgical modalities, including thymoma treatment approaches (63 citations) and early-stage NSCLC lobectomy in over 1,075 patients (61 citations). Notably, Hao has contributed rare randomized controlled trial evidence demonstrating that RATS achieves comparable long-term survival to thoracotomy in clinically node-positive NSCLC patients while reducing perioperative complications. His more recent investigations into domestically developed Chinese surgical robots reflect a commitment to expanding accessible robotic surgical technology. Collectively, his body of work has garnered nearly 340 citations, cementing his status as a leading voice in minimally invasive thoracic surgery.